These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20600926)

  • 41. Neuroprotection by Neurotropin through Crosstalk of Neurotrophic and Innate Immune Receptors in PC12 Cells.
    Fukuda Y; Nakajima K; Mutoh T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Timing of Treatment with the Flavonoid 7,8-DHF Critically Impacts on Its Effects on Learning and Memory in the Ts65Dn Mouse.
    Giacomini A; Stagni F; Emili M; Uguagliati B; Rimondini R; Bartesaghi R; Guidi S
    Antioxidants (Basel); 2019 Jun; 8(6):. PubMed ID: 31174258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neurotropin reduces memory impairment and neuroinflammation via BDNF/NF-κB in a transgenic mouse model of Alzheimer's disease.
    Fang W; Liao W; Zheng Y; Huang X; Weng X; Fan S; Chen X; Zhang X; Chen J; Xiao S; Thea A; Luan P; Liu J
    Am J Transl Res; 2019; 11(3):1541-1554. PubMed ID: 30972181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.
    Parrini M; Ghezzi D; Deidda G; Medrihan L; Castroflorio E; Alberti M; Baldelli P; Cancedda L; Contestabile A
    Sci Rep; 2017 Dec; 7(1):16825. PubMed ID: 29203796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
    Kazim SF; Blanchard J; Bianchi R; Iqbal K
    Sci Rep; 2017 Apr; 7():45561. PubMed ID: 28368015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurotropin® alleviates hippocampal neuron damage through a HIF-1α/MAPK pathway.
    Fang WL; Zhao DQ; Wang F; Li M; Fan SN; Liao W; Zheng YQ; Liao SW; Xiao SH; Luan P; Liu J
    CNS Neurosci Ther; 2017 May; 23(5):428-437. PubMed ID: 28271615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.
    Carvalho IM; Coelho PB; Costa PC; Marques CS; Oliveira RS; Ferreira DC
    Neuromolecular Med; 2015 Dec; 17(4):404-22. PubMed ID: 26374113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief.
    Kanbayashi Y; Onishi K; Hosokawa T
    Pain Res Manag; 2014; 19(6):e164-7. PubMed ID: 24945288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular rescue of DYRK1A overexpression in cystathionine beta synthase-deficient mouse brain by enriched environment combined with voluntary exercise.
    Souchet B; Latour A; Gu Y; Daubigney F; Paul JL; Delabar JM; Janel N
    J Mol Neurosci; 2015 Feb; 55(2):318-23. PubMed ID: 24819931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospects for improving brain function in individuals with Down syndrome.
    Costa AC; Scott-McKean JJ
    CNS Drugs; 2013 Sep; 27(9):679-702. PubMed ID: 23821040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Over-expression of mitochondrial antiviral signaling protein inhibits coxsackievirus B3 infection by enhancing type-I interferons production.
    Zhang QM; Song WQ; Li YJ; Qian J; Zhai AX; Wu J; Li AM; He JM; Zhao JY; Yu X; Wei LL; Zhang FM
    Virol J; 2012 Dec; 9():312. PubMed ID: 23249700
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities.
    Rueda N; Flórez J; Martínez-Cué C
    Neural Plast; 2012; 2012():584071. PubMed ID: 22685678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients.
    Tlili A; Hoischen A; Ripoll C; Benabou E; Badel A; Ronan A; Touraine R; Grattau Y; Stora S; van Bon B; de Vries B; Menten B; Bockaert N; Gecz J; Antonarakis SE; Campion D; Potier MC; Bléhaut H; Delabar JM; Janel N
    Mol Neurobiol; 2012 Oct; 46(2):297-303. PubMed ID: 22669612
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin.
    Fukuda Y; Berry TL; Nelson M; Hunter CL; Fukuhara K; Imai H; Ito S; Granholm-Bentley AC; Kaplan AP; Mutoh T
    Mol Cell Neurosci; 2010 Nov; 45(3):226-33. PubMed ID: 20600926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethanol inhibits brain-derived neurotrophic factor-mediated intracellular signaling and activator protein-1 activation in cerebellar granule neurons.
    Li Z; Ding M; Thiele CJ; Luo J
    Neuroscience; 2004; 126(1):149-62. PubMed ID: 15145081
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Norepinephrine induces BDNF and activates the PI-3K and MAPK cascades in embryonic hippocampal neurons.
    Chen MJ; Nguyen TV; Pike CJ; Russo-Neustadt AA
    Cell Signal; 2007 Jan; 19(1):114-28. PubMed ID: 16876982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain-derived neurotrophic factor, phosphorylated cyclic AMP response element binding protein and neuropeptide Y decline as early as middle age in the dentate gyrus and CA1 and CA3 subfields of the hippocampus.
    Hattiangady B; Rao MS; Shetty GA; Shetty AK
    Exp Neurol; 2005 Oct; 195(2):353-71. PubMed ID: 16002067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons.
    Wang R; Li YH; Xu Y; Li YB; Wu HL; Guo H; Zhang JZ; Zhang JJ; Pan XY; Li XJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):147-53. PubMed ID: 19879308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.